Noromycin

Noromycin 300 LA – 500ml Effectively treat a variety of livestock diseases with one convenient antibiotic. Noromycin 300 LA is a broad-spectrum injectable antibiotic approved for use in beef cattle, non-lactating dairy cattle, calves (including veal calves) and swine for the treatment of the following diseases:Noromycin 300 LA – 500ml

Noromycin 300 LA – 500ml

MORE ACTIVE INGREDIENT IN A SMALLER DOSE

Delivers 300 mg of oxytetracycline per mL. Only 3 mL per 100 pounds of body weight. Provides sustained blood levels for up to 4 days. Use for treatment of pneumonia, shipping fever complex, pinkeye, wounds, infections or foot rot, scours, and leptospirosis. Recommended for use in beef cattle, non-lactating dairy cattle, calves, and swine.

Noromycin 300 LA – 500ml KEY BENEFITS:

• non-prescription antibiotic injection
• contains 300 mg Oxytetracycline per mL
• provides sustained blood level for up to 4 days

Cattle Dosage: 3 mL SQ or IM per 100 lbs.
Swine Dosage: 3 mL SQ or IM per 100 lbs.

Note: 28 day slaughter withdrawal.

Any use of a product that is not clearly defined on the label directions should only be done under supervision of a qualified veterinary professional.

INTRODUCTION of Noromycin 300 LA – 500ml :

Noromycin 300 LA is a sterile, ready to use solution of the broad-spectrum antibiotic oxytetracycline dihydrate. Oxytetracycline is an antimicrobial agent that is effective in treatment of a wide range of diseases caused by susceptible gram-positive and gram-negative bacteria.

Noromycin 300 LA should be stored at room temperature 59°-86ºF (15º-30ºC). The antibiotic activity of oxytetracycline is not appreciably diminished in the presence of body fluids, serum or exudates.

INDICATIONS of Noromycin 300 LA – 500ml :

Noromycin 300 LA is intended for use in treatment for the following diseases when due to oxytetracycline-susceptible organisms:

Beef cattle, non-lactating dairy cattle, calves, including pre-ruminating (veal) calves:

Noromycin 300 LA is indicated in the treatment of pneumonia and shipping fever complex associated with Pasteurella spp., and Histophilus spp. Noromycin 300 LA is indicated for the treatment of infectious bovine keratoconjunctivitis (pink eye) caused by Moraxella bovis, foot-rot and diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii; leptospirosis caused by Leptospira pomona; and wound infections and acute metritis caused by strains of staphylococcal and streptococcal organisms sensitive to oxytetracycline.

Swine:

Noromycin 300 LA is indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.

In sows Noromycin 300 LA is indicated as an aid in control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.

DOSAGE AND ADMINISTRATION for Noromycin 300 LA – 500ml :

Beef cattle, non-lactating dairy cattle, calves, including pre-ruminating (veal) calves:

A single dosage of 9 mg of oxytetracycline per pound of bodyweight administered intramuscularly or subcutaneously is recommended in the treatment of the following conditions:

1. Bacterial pneumonia caused by Pasteurella spp (shipping fever) in calves and yearlings where retreatment is impractical due to husbandry conditions, such as cattle on range, or where their repeated restraint is inadvisable.
2. Infectious bovine kertaconjunctivitis (pink eye) caused by Moraxella bovis.

For other indications Noromycin 300 LA is to be administered intramuscularly, subcutaneously or intravenously at a level of 3 to 5 mg of oxytetracycline per pound of bodyweight per day. In treatment of foot-rot and advanced cases of other indicated diseases, a dosage level of 5 mg per pound of bodyweight per day is recommended. Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four (4) consecutive days. If improvement is not noted within 24 to 48 hours of the beginning of treatment, diagnosis and therapy should be re-evaluated by a veterinarian.